CTOR vs FTV · $105.2M cap vs P/E 31, rev $6.23B
Citius Oncology, Inc. (CTOR) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
CTOR currently screens at market cap $105.2M. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the CTOR and FTV stock pages for the full models.
Not investment advice.